Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural dexmedetomidine dose-finding with ropivacaine for interscalene block plus IV dexamethasone
2023-506062-31-00Phase 4Withdrawn
- Sponsor
- AZ Rivierenland
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, ropivacaine and dexamethasone in postoperative pain (3 arms), sponsored by AZ Rivierenland. Primary endpoint: Length of analgesia. Planned start Aug 2023; status: withdrawn.
02
Drugs
dexmedetomidineropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2023-506062-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506062-31-00.